Biological Products, (No Diagnostic Substances) · DE · CIK 1817241
Develops off-the-shelf NK cell therapies for blood cancers and solid tumors
Comparable business profile · signals at a glance
In the 90 days to Dec 15, 2025: 1 sold $194K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Aslan FredPresident and CEO | Sell | 3,187 | $6.00 | $19K |
| Nov 17, 2025 | Aslan FredPresident and CEO | Sell | 6,375 | $3.38 | $22K |
| Oct 17, 2025 | Aslan FredPresident and CEO | Sell | 25,500 | $6.00 | $153K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.